Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | NFATC3 |
Upstream (Parents) |
---|
(<<) ACTB → NFATC3 |
(<<) ARHGEF2 → NFATC3 |
(<<) ATP2A2 → NFATC3 |
(<<) ENO1 → NFATC3 |
(<<) FOXO3 → NFATC3 |
(<<) GAPDH → NFATC3 |
(<<) MCL1 → NFATC3 |
(<<) NFKB2 → NFATC3 |
(<<) PPIB → NFATC3 |
(<<) RAC2 → NFATC3 |
(<<) RAVER1 → NFATC3 |
(<<) RHOA → NFATC3 |
(<<) RPS16 → NFATC3 |
(<<) THOC4 → NFATC3 |
(<<) TPP1 → NFATC3 |
Downstream (Children) |
---|
NFATC3 → CIRH1A (>>) |
NFATC3 → COL13A1 (>>) |
NFATC3 → EVX1 (>>) |
NFATC3 → LRP5 (>>) |
NFATC3 → MSN (>>) |
NFATC3 → NDST1 (>>) |
NFATC3 → NFKBIZ (>>) |
NFATC3 → PHLDA2 (>>) |
NFATC3 → PLEK2 (>>) |
NFATC3 → RAB15 (>>) |
NFATC3 → RASD1 (>>) |
NFATC3 → RHOT1 (>>) |
NFATC3 → RPL26L1 (>>) |
NFATC3 → TMEFF2 (>>) |